Getein Biotech, Inc

SSE:603387.SS

8.24 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q1
Revenue 244.148284.974262.157296.085321.583368.2297.605319.041384.316444.693403.956402.496570.715479.545321.868324.308275.98360.432383.029231.712148.162337.649189.608234.381206.566232.597143.997166.046143.598158.363119.205118.5492.474120.43779.8295.40973.42656.405
Cost of Revenue 55.79689.46879.06898.15591.733119.839101.896115.258109.072197.283120.581148.045170.484161.454113.512103.857103.638131.66151.72381.98649.92881.15856.78568.15457.31757.10727.3235.27125.07234.46118.13318.18316.55620.41415.33517.81115.7938.387
Gross Profit 188.353195.506183.089197.93229.85248.361195.709203.782275.245247.41283.376254.451400.231318.091208.356220.451172.342228.772231.306149.72698.234256.491132.823166.228149.249175.49116.677130.775118.526123.902101.072100.35775.918100.02364.48477.59757.63348.018
Gross Profit Ratio 0.7710.6860.6980.6680.7150.6750.6580.6390.7160.5560.7020.6320.7010.6630.6470.680.6240.6350.6040.6460.6630.760.7010.7090.7230.7540.810.7880.8250.7820.8480.8470.8210.8310.8080.8130.7850.851
Reseach & Development Expenses 43.45843.98144.81248.41144.00357.34153.36352.12455.16571.32752.80248.16850.92444.02941.68841.73935.93833.05533.54830.06622.39933.30629.52921.8820.01730.62918.817.24613.9221.05412.62620.361039.283016.12707.203
General & Administrative Expenses 19.36-39.03552.952-8.91722.276-47.48163.312-17.37529.107-41.03254.407-7.02528.505-24.17240.418-3.92217.644-18.73614.508-2.16513.446-24.68318.447-1.75214.965-14.43511.821-13.88423.447-45.07923.412-10.37415.952-35.46815.66729.064012.057
Selling & Marketing Expenses 53.122-91.9168.32578.89266.56493.15688.46997.11368.703102.4264.32774.54862.0382.57453.66652.43444.83674.37145.17839.8823.30757.75336.12145.02535.20457.06335.74834.44524.79538.4222.93826.06714.4225.81115.95333.018010.116
SG&A 72.482-130.934221.27769.97688.8445.674151.78179.73897.8161.387118.73467.52490.53458.40294.08448.51262.4855.63659.68637.71536.75333.0754.56843.27250.16942.62947.56820.56148.242-6.6646.3515.69330.372-9.65731.6262.198022.173
Other Expenses 3.173228.368-120.3-0.147-0.377-2.0030.5190.301-7.64268.642-33.49235.939-2.071-4.949-0.495-1.461.453-1.874-0.997-0.551-0.534-1.593-1.6820.2280.1044.506-00.236-0.01-6.1022.0463.2151.6980.7366.567-37.968-25.3570.449
Operating Expenses 119.113141.414118.973141.299129.585177.256165.045167.182145.332201.357138.044151.631139.387158.509110.97117.05696.375127.91588.15887.22357.46194.21984.76983.91363.734107.93266.50365.8249.35458.44248.14347.51931.90252.53532.708-37.968-25.35723.236
Operating Income 69.2454.09264.11666.228100.43256.96861.32149.737138.56322.352162.355134.719243.83155.501102.24122.2572.798129.645136.62660.53751.189164.05454.12982.58298.14873.86558.55174.05476.06970.83253.57753.67145.01548.19932.51539.6332.27624.592
Operating Income Ratio 0.2840.190.2450.2240.3120.1550.2060.1560.3610.050.4020.3350.4270.3240.3180.3770.2640.360.3570.2610.3450.4860.2850.3520.4750.3180.4070.4460.530.4470.4490.4530.4870.40.4070.4150.440.436
Total Other Income Expenses Net -1.69-3.186-0.723-0.16.772-1.425.903-0.222-1.586-3.93617.962-1.983-2.334-3.358.26313.060.293-2.085-0.085-0.55111.206-2.625.2550.56112.9174.5068.3769.6426.887-6.0852.033.2151.6981.9167.3320.3031.4840.425
Income Before Tax 67.5550.90663.39366.128100.05555.54862.36249.515137.51620.172162.21134.118243.478154.847101.744120.7974.252127.771135.62959.98650.655162.46152.44782.8198.25278.37158.55174.29176.05964.74755.60756.88746.71348.86839.10839.93333.7625.041
Income Before Tax Ratio 0.2770.1790.2420.2230.3110.1510.210.1550.3580.0450.4020.3330.4270.3230.3160.3720.2690.3540.3540.2590.3420.4810.2770.3530.4760.3370.4070.4470.530.4090.4660.480.5050.4060.490.4190.460.444
Income Tax Expense 5.2472.9325.3542.64912.6185.130.2792.30613.145-2.70114.34621.60522.7854.95916.86911.8415.95319.33915.472.7216.19817.6286.37410.76611.2558.4448.8359.8649.4838.7837.3548.1685.8696.3526.15732.799-20.0613.852
Net Income 64.30748.21855.47660.79586.01350.70260.3547.194121.52623.709145.399111.081218.721145.87582.259108.19562.661107.61101.18152.69543.247140.80445.01468.8548569.3849.6864.01666.53656.00648.38448.740.89742.33533.14534.41428.46321.498
Net Income Ratio 0.2630.1690.2120.2050.2670.1380.2030.1480.3160.0530.360.2760.3830.3040.2560.3340.2270.2990.2640.2270.2920.4170.2370.2940.4110.2980.3450.3860.4630.3540.4060.4110.4420.3520.4150.3610.3880.381
EPS 0.130.0960.110.120.170.10.120.0930.240.0470.410.310.430.290.230.30.120.290.190.140.0610.40.0920.190.170.190.140.180.130.160.10.180.110.150.0860.120.0750.057
EPS Diluted 0.130.0960.110.120.170.10.120.0930.240.0470.410.310.430.290.230.30.120.290.190.140.0610.40.0870.190.170.190.140.180.130.160.10.180.110.150.0860.120.0750.057
EBITDA 71.24153.7340.53771.125130.33384.79193.50587.574160.47943.712188.615156.441265.783172.361118.529138.1691.385138.783137.11373.87762.831170.46154.61790.629106.7467.55850.17464.95669.17265.4654.81552.83845.7148.44131.77612.3557.63324.949
EBITDA Ratio 0.2920.1890.1550.240.4050.230.3140.2740.4180.0980.4670.3890.4660.3590.3680.4260.3310.3850.3580.3190.4240.5050.2880.3870.5170.290.3480.3910.4820.4130.460.4460.4940.4020.3980.1290.7850.442